Inspire Medical Systems Inc. announced that it expects to release a significant portion of the valuation allowance on its U.S. deferred tax assets in the fourth quarter of fiscal 2025. This action is projected to result in an income tax benefit of between $90 million and $100 million for the year, which is expected to increase diluted earnings per share by approximately $3.00 to $3.30 for the same period.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001609550-25-000055), on November 17, 2025, and is solely responsible for the information contained therein.